Literature DB >> 23447110

Fe(III) distribution varies substantially within and between atherosclerotic plaques.

H Gustafsson1, M Hallbeck, M Norell, M Lindgren, M Engström, A Rosén, H Zachrisson.   

Abstract

PURPOSE: Vulnerable atherosclerotic plaques are structurally weak and prone to rupture, presumably due to local oxidative stress. Redox active iron is linked to oxidative stress and the aim of this study was to investigate the distribution of Fe(III) in carotid plaques and its relation to vulnerability for rupture.
METHODS: Atherosclerotic plaques from 10 patients (three asymptomatic and seven symptomatic) were investigated. Plaque vulnerability was classified using ultrasound and immunohistochemistry and correlated to Fe(III) measured by electron paramagnetic resonance spectroscopy.
RESULTS: Large intra-plaque Fe(III) variations were found. Plaques from symptomatic patients had a higher Fe(III) concentration as compared with asymptomatic plaques (0.36 ± 0.21 vs. 0.06 ± 0.04 nmol Fe(III)/mg tissue, P < 0.05, in sections adjoining narrowest part of the plaques). All but one plaque from symptomatic patients showed signs of cap rupture. No plaque from asymptomatic patients showed signs of cap rupture. There was a significant increase in cap macrophages in plaques from symptomatic patients compared with asymptomatic patients (31 ± 11% vs. 2.3 ± 2.3%, P < 0.01).
CONCLUSION: Fe(III) distribution varies substantially within atherosclerotic plaques. Plaques from symptomatic patients had significantly higher concentrations of Fe(III), signs of cap rupture and increased cap macrophage activity.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23447110     DOI: 10.1002/mrm.24687

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

Review 1.  Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

Authors:  Driton Vela
Journal:  Lab Invest       Date:  2017-10-23       Impact factor: 5.662

Review 2.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

Review 3.  Iron in Cardiovascular Disease: Challenges and Potentials.

Authors:  Shizhen Li; Xiangyu Zhang
Journal:  Front Cardiovasc Med       Date:  2021-11-30

Review 4.  Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases.

Authors:  Fang Yan; Kaifeng Li; Wenjuan Xing; Mingqing Dong; Mingliang Yi; Haifeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-09-07       Impact factor: 7.310

Review 5.  Intravenous iron therapy and the cardiovascular system: risks and benefits.

Authors:  Lucia Del Vecchio; Robert Ekart; Charles J Ferro; Jolanta Malyszko; Patrick B Mark; Alberto Ortiz; Pantelis Sarafidis; Jose M Valdivielso; Francesca Mallamaci
Journal:  Clin Kidney J       Date:  2020-11-26

Review 6.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.